| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| IRWD | IRWD | Shares | USD | XNGS |
| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| IRWD | IRWD | Shares | USD | XNGS |
Ironwood Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of gastrointestinal (GI) diseases. It discovers, develops, and commercializes medications, including LINZESS® (linaclotide), aimed at improving patient care in the GI field. The company leverages insights and expertise to address critical patient needs and collaborates with the GI community to advance treatment options.
No recent RNS announcements for IRWD across IRWD.
No recent RNS announcements for IRWD across IRWD.